SenesTech, Inc. (SNES)
NASDAQ: SNES · IEX Real-Time Price · USD
1.27
-0.46 (-26.59%)
At close: Dec 29, 2023, 4:00 PM
1.20
-0.07 (-5.51%)
After-hours: Dec 29, 2023, 7:59 PM EST
Company Description
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control.
The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. SenesTech, Inc. was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc.
| Country | United States |
| Founded | 2004 |
| IPO Date | Dec 8, 2016 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 29 |
| CEO | Joel L. Fruendt |
Contact Details
Address: 3140 N. Caden Court, Suite 1 Flagstaff, Arizona 86004 United States | |
| Phone | (928) 779 - 4143 |
| Website | senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R208 |
| ISIN Number | US81720R5054 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer and Assistant Secretary |
| Dr. Steven C. Krause Ph.D. | Executive Vice President of Sales and Marketing |
| Kenneth S. Siegel | Executive Director |
| Joel Fruendt | Chief Executive Officer and Director |
| Kim Patrice Wolin | Executive Vice President of Operations and Secretary |
| Nicole Williams | Chief Strategy Officer |
| Paul M. Palz | Vice President and Corporate Controller |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 29, 2023 | 8-K | Current Report |
| Nov 29, 2023 | 424B4 | Prospectus |
| Nov 27, 2023 | EFFECT | Notice of Effectiveness |
| Nov 27, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 22, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 22, 2023 | 8-K | Current Report |
| Nov 15, 2023 | 8-K | Current Report |
| Nov 9, 2023 | 10-Q | Quarterly Report |
| Nov 9, 2023 | 8-K | Current Report |
| Oct 17, 2023 | EFFECT | Notice of Effectiveness |